BEIGENE, LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 198.49 USD | +1.13% |
|
+3.75% | +10.05% |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Pharmaceutical Products | 428M | 309M | 1.18B | 1.42B | 2.46B | |||||
Total Assets | 1.61B | 5.6B | 8.65B | 6.38B | 5.81B | |||||
Interest Expense | -10.3M | -17.97M | -28.21M | -19.1M | -4.23M | |||||
Income Tax Expense | 6.99M | -17.67M | -25.23M | 42.78M | 55.87M | |||||
CAPEX | -159M | -227M | -315M | -469M | -562M | |||||
EBT | -944M | -1.62B | -1.44B | -1.96B | -826M | |||||
Gross Profit | - | - | - | - | 2.08B | |||||
D&A | 18.62M | 31.79M | 45.49M | 66.28M | 83.94M | |||||
Operating Income | -960M | -1.66B | -1.44B | -1.79B | -1.21B | |||||
Net Income | -949M | -1.6B | -1.41B | -2B | -882M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
United States (U.S) | 135M | 18.23M | 495M | 503M | 1.13B | |||||
Total Assets | - | - | 65.48M | - | - | |||||
China | 222M | 291M | 517M | 840M | 1.1B | |||||
Total Assets | 1.61B | 5.6B | 8.58B | - | - | |||||
Interest Expense | - | - | - | - | - | |||||
Income Tax Expense | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Net Income | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Europe | - | - | - | - | 202M | |||||
Rest of World | 71.97M | - | 164M | 73.26M | 26.6M |
- Stock Market
- Equities
- BGNE Stock
- Financials BeiGene, Ltd.
- Business Segments
MarketScreener is also available in this country: United States.
Switch edition